1h Free Analyst Time
The publisher has been monitoring the coenzyme Q10 market and it is poised to grow by $ 242.36 mn during 2021-2025, progressing at a CAGR of 6.13% during the forecast period. The report on the coenzyme Q10 market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by growing disposable incomes, increase in older adult population, and rising focus on healthy dietary habits.
The coenzyme Q10 market analysis includes the application segment and geographic landscape.
The coenzyme Q10 market is segmented as below:
By Application
- Dietary supplements
- Pharmaceuticals
- Cosmetics
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the increase in health concerns as one of the prime reasons driving the coenzyme Q10 market growth during the next few years. Also, high demand for cosmetics and growth in online sales will lead to sizable demand in the market.
The report on coenzyme Q10 market covers the following areas:
- Coenzyme Q10 market sizing
- Coenzyme Q10 market forecast
- Coenzyme Q10 market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coenzyme Q10 market vendors that include Kaneka Corp., Kikkoman Corp., Kirin Holdings Co. Ltd., Koninklijke DSM NV, Lesaffre and Cie, Nisshin Seifun Group Inc., Otsuka Holdings Co. Ltd., Pharma Nord Inc., PharmaEssentia Corp., and Zhejiang Medicine Co. Ltd. Also, the coenzyme Q10 market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Application
- Market segments
- Comparison by Application
- Dietary supplements - Market size and forecast 2020-2025
- Pharmaceuticals - Market size and forecast 2020-2025
- Cosmetics - Market size and forecast 2020-2025
- Market opportunity by Application
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Kaneka Corp.
- Kikkoman Corp.
- Kirin Holdings Co. Ltd.
- Koninklijke DSM NV
- Lesaffre and Cie
- Nisshin Seifun Group Inc.
- Otsuka Holdings Co. Ltd.
- Pharma Nord Inc.
- PharmaEssentia Corp.
- Zhejiang Medicine Co. Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Application - Market share 2020-2025 (%)
- Comparison by Application
- Dietary supplements - Market size and forecast 2020-2025 ($ million)
- Dietary supplements - Year-over-year growth 2020-2025 (%)
- Pharmaceuticals - Market size and forecast 2020-2025 ($ million)
- Pharmaceuticals - Year-over-year growth 2020-2025 (%)
- Cosmetics - Market size and forecast 2020-2025 ($ million)
- Cosmetics - Year-over-year growth 2020-2025 (%)
- Market opportunity by Application
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Kaneka Corp. - Overview
- Kaneka Corp. - Business segments
- Kaneka Corp. - Key offerings
- Kaneka Corp. - Key customers
- Kaneka Corp. - Segment focus
- Kikkoman Corp. - Overview
- Kikkoman Corp. - Business segments
- Kikkoman Corp. - Key offerings
- Kikkoman Corp. - Key customers
- Kikkoman Corp. - Segment focus
- Kirin Holdings Co. Ltd. - Overview
- Kirin Holdings Co. Ltd. - Business segments
- Kirin Holdings Co. Ltd. - Key offerings
- Kirin Holdings Co. Ltd. - Key customers
- Kirin Holdings Co. Ltd. - Segment focus
- Koninklijke DSM NV - Overview
- Koninklijke DSM NV - Business segments
- Koninklijke DSM NV - Key offerings
- Koninklijke DSM NV - Key customers
- Koninklijke DSM NV - Segment focus
- Lesaffre and Cie - Overview
- Lesaffre and Cie - Product and service
- Lesaffre and Cie - Key offerings
- Lesaffre and Cie - Key customers
- Lesaffre and Cie - Segment focus
- Nisshin Seifun Group Inc. - Overview
- Nisshin Seifun Group Inc. - Business segments
- Nisshin Seifun Group Inc. - Key offerings
- Nisshin Seifun Group Inc. - Key customers
- Nisshin Seifun Group Inc. - Segment focus
- Otsuka Holdings Co. Ltd. - Overview
- Otsuka Holdings Co. Ltd. - Business segments
- Otsuka Holdings Co. Ltd. - Key offerings
- Otsuka Holdings Co. Ltd. - Key customers
- Otsuka Holdings Co. Ltd. - Segment focus
- Pharma Nord Inc. - Overview
- Pharma Nord Inc. - Product and service
- Pharma Nord Inc. - Key offerings
- Pharma Nord Inc. - Key customers
- Pharma Nord Inc. - Segment focus
- PharmaEssentia Corp. - Overview
- PharmaEssentia Corp. - Business segments
- PharmaEssentia Corp. - Key offerings
- PharmaEssentia Corp. - Key customers
- PharmaEssentia Corp. - Segment focus
- Zhejiang Medicine Co. Ltd. - Overview
- Zhejiang Medicine Co. Ltd. - Product and service
- Zhejiang Medicine Co. Ltd. - Key offerings
- Zhejiang Medicine Co. Ltd. - Key customers
- Zhejiang Medicine Co. Ltd. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global coenzyme q10 market: Kaneka Corp., Kikkoman Corp., Kirin Holdings Co. Ltd., Koninklijke DSM NV, Lesaffre and Cie, Nisshin Seifun Group Inc., Otsuka Holdings Co. Ltd., Pharma Nord Inc., PharmaEssentia Corp., and Zhejiang Medicine Co. Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increase in health concerns.`
According to the report, one of the major drivers for this market is the growing disposable income.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Kaneka Corp.
- Kikkoman Corp.
- Kirin Holdings Co. Ltd.
- Koninklijke DSM NV
- Lesaffre and Cie
- Nisshin Seifun Group Inc.
- Otsuka Holdings Co. Ltd.
- Pharma Nord Inc.
- PharmaEssentia Corp.
- Zhejiang Medicine Co. Ltd.
